These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 31658631

  • 21. Synthesis of novel 2-aminobenzothiazole derivatives as potential antimicrobial agents with dual DNA gyrase/topoisomerase IV inhibition.
    Ismail MMF, Abdulwahab HG, Nossier ES, El Menofy NG, Abdelkhalek BA.
    Bioorg Chem; 2020 Jan; 94():103437. PubMed ID: 31812260
    [Abstract] [Full Text] [Related]

  • 22. Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines.
    Werner MM, Patel BA, Talele TT, Ashby CR, Li Z, Zauhar RJ.
    Bioorg Med Chem; 2015 Sep 15; 23(18):6125-37. PubMed ID: 26320664
    [Abstract] [Full Text] [Related]

  • 23. Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1,2,4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors.
    Mohamed NG, Sheha MM, Hassan HY, Abdel-Hafez LJM, Omar FA.
    Bioorg Chem; 2018 Dec 15; 81():599-611. PubMed ID: 30248511
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Discovery of novel oxoindolin derivatives as atypical dual inhibitors for DNA Gyrase and FabH.
    Yang YS, Su MM, Xu JF, Liu QX, Bai LF, Hu XW, Zhu HL.
    Bioorg Chem; 2019 Dec 15; 93():103309. PubMed ID: 31585266
    [Abstract] [Full Text] [Related]

  • 27. N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification.
    Xue W, Li X, Ma G, Zhang H, Chen Y, Kirchmair J, Xia J, Wu S.
    Eur J Med Chem; 2020 Feb 15; 188():112022. PubMed ID: 31901744
    [Abstract] [Full Text] [Related]

  • 28. Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors.
    Cotman AE, Trampuž M, Brvar M, Kikelj D, Ilaš J, Peterlin-Mašič L, Montalvão S, Tammela P, Frlan R.
    Arch Pharm (Weinheim); 2017 Aug 15; 350(8):. PubMed ID: 28621824
    [Abstract] [Full Text] [Related]

  • 29. Improved N-phenylpyrrolamide inhibitors of DNA gyrase as antibacterial agents for high-priority bacterial strains.
    Zidar N, Onali A, Peršolja P, Benedetto Tiz D, Dernovšek J, Skok Ž, Durcik M, Cotman AE, Hrast Rambaher M, Cruz CD, Tammela P, Senerovic L, Jovanovic M, Szili PÉ, Czikkely MS, Pál C, Zega A, Peterlin Mašič L, Ilaš J, Tomašič T, Kikelj D.
    Eur J Med Chem; 2024 Nov 15; 278():116823. PubMed ID: 39236496
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors.
    Mohammed HHH, Ali DME, Badr M, Habib AGK, Mahmoud AM, Farhan SM, Gany SSHAE, Mohamad SA, Hayallah AM, Abbas SH, Abuo-Rahma GEA.
    Mol Divers; 2023 Aug 15; 27(4):1751-1765. PubMed ID: 36152132
    [Abstract] [Full Text] [Related]

  • 31. Novel 2-arylbenzothiazole DNA gyrase inhibitors: Synthesis, antimicrobial evaluation, QSAR and molecular docking studies.
    Ghannam IAY, Abd El-Meguid EA, Ali IH, Sheir DH, El Kerdawy AM.
    Bioorg Chem; 2019 Dec 15; 93():103373. PubMed ID: 31698294
    [Abstract] [Full Text] [Related]

  • 32. Design, dynamic docking, synthesis, and in vitro validation of a novel DNA gyrase B inhibitor.
    Pudipeddi A, Vasudevan S, Shanmugam K, Mohan S S, Vairaprakash P, Neelakantan P, Balraj AS, Solomon AP.
    J Biomol Struct Dyn; 2023 Dec 15; 41(13):6345-6358. PubMed ID: 35924774
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
    Mitton-Fry MJ, Brickner SJ, Hamel JC, Barham R, Brennan L, Casavant JM, Ding X, Finegan S, Hardink J, Hoang T, Huband MD, Maloney M, Marfat A, McCurdy SP, McLeod D, Subramanyam C, Plotkin M, Reilly U, Schafer J, Stone GG, Uccello DP, Wisialowski T, Yoon K, Zaniewski R, Zook C.
    Bioorg Med Chem Lett; 2017 Aug 01; 27(15):3353-3358. PubMed ID: 28610977
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Structure based design and synthesis of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives as novel bacterial DNA-gyrase inhibitors: In-vitro, In-vivo, In-silico and SAR studies.
    Saleh MA, Elmaaty AA, El Saeed HS, Saleh MM, Salah M, Ezz Eldin RR.
    Bioorg Chem; 2022 Dec 01; 129():106186. PubMed ID: 36215786
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Targeted potent antimicrobial benzochromene-based analogues: Synthesis, computational studies, and inhibitory effect against 14α-Demethylase and DNA Gyrase.
    Fouda AM, Hassan AH, Eliwa EM, Ahmed HEA, Al-Dies AM, Omar AM, Nassar HS, Halawa AH, Aljuhani N, El-Agrody AM.
    Bioorg Chem; 2020 Dec 01; 105():104387. PubMed ID: 33130344
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.